Medicine guide
Harvoni
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Ledispavir;sofosbuvir
- Made by
- Gilead Sciences Ireland UC
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Harvoni is indicated for the treatment of chronic hepatitis C (CHC) in adult and paediatric patients aged 3 years and above (see sections 4.2, 4.4 and 5.1). For hepatitis C virus (HCV) genotype-specific activity see sections 4.4 and 5.1.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Gilead Sciences Ireland UC |
|---|---|
| Active substance | Ledispavir;sofosbuvir |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AX65 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2014-11-17 |
| Last updated by the regulator | 2026-01-09 |
| EMA product number | EMEA/H/C/003850 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).